MEI Pharma, Inc. (MEIP)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.91-0.07 (-3.54%)
At close: 4:00 PM EDT
People also watch:
OHRPCNATATNMVSTMACRX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open1.98
Prev Close1.98
Bid1.89 x 6000
Ask1.96 x 6000
Day's Range1.90 - 2.01
52wk Range0.87 - 2.28
1y Target EstN/A
Market Cap65.24M
P/E Ratio (ttm)-3.16
Beta2.09
Volume483,717
Avg Vol (3m)509,582
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire19 days ago

    MEI Pharma to Present at Wedbush PacGrow Healthcare Conference

    SAN DIEGO, Aug. 10, 2016 /PRNewswire/ -- MEI Pharma, Inc. (MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present at the Wedbush PacGrow Healthcare Conference on Tuesday, August 16, 2016 at 8:00 a.m. Eastern time from Le Parker Meridien in New York. MEI Pharma, Inc. (MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.

  • Trading Week Kicks Off With A Bang for Wal-Mart and 4 Other Stocks
    Insider Monkey21 days ago

    Trading Week Kicks Off With A Bang for Wal-Mart and 4 Other Stocks

    Disappointing trade figures out of China have investors on edge this morning as the trading week kicks off. Exports from the country dipped by 4.4% year-over-year in July, while imports crumbled by 12.5%. While the figures have some blaming the Brexit, Chinese exports also slid by 4.8% in June. Among the companies grabbing investors’ attention […]

  • MarketWatch21 days ago

    MEI Pharma shares jump 51% in pre-market trade after $20 mln drug deal

    MEI Pharma Inc. shares rose as much as 51% in pre-market trade Monday after the company said it entered a $20 million deal with Swiss pharmaceutical group Helsinn to license, develop and commercialize ...